REVANCE THERAPEUTICS INC shareholders Q1 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
PICTET ASSET MANAGEMENT SA 11,770$379,1120.00%
MASSMUTUAL TRUST CO FSB/ADV 114$3,6720.00%
UBS Group AG 10,000$322,1000.00%
SIMPLEX TRADING, LLC 15,581$5010.00%
Global Retirement Partners, LLC 9$3020.00%
Walleye Trading LLC 300$9,6630.00%
STRS OHIO 1,800$570.00%
CWM, LLC 185$60.00%
Schubert & Co 1$330.00%
Point72 Asset Management, L.P. 3,100$99,8510.00%
Disciplined Investments, LLC 1$320.00%
Walleye Capital LLC 700$22,5470.00%
ENVESTNET ASSET MANAGEMENT INC 19,373$624,0040.00%
AdvisorNet Financial, Inc 1$320.00%
PNC FINANCIAL SERVICES GROUP, INC. 650$20,9360.00%
CITIGROUP INC 11,960$385,2320.00%
NISA INVESTMENT ADVISORS, LLC 660$210.00%
Parallel Advisors, LLC 11$3540.00%
CANADA LIFE ASSURANCE Co 4,196$1350.00%
Citadel Advisors 49,600$1,597,6160.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q1 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.